Rxsight Financial Statements From 2010 to 2025

RXST Stock  USD 15.24  0.68  4.67%   
Analyzing historical trends in various income statement and balance sheet accounts from Rxsight's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Rxsight's valuation are summarized below:
Gross Profit
98.9 M
Profit Margin
(0.20)
Market Capitalization
591.4 M
Enterprise Value Revenue
2.6192
Revenue
139.9 M
There are currently one hundred twenty trending fundamental ratios for Rxsight that can be evaluated and compared over time across competitors. All traders should check out Rxsight's recent fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 676.8 M in 2025. Enterprise Value is likely to drop to about 685.3 M in 2025

Rxsight Total Revenue

146.92 Million

Check Rxsight financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rxsight's main balance sheet or income statement drivers, such as Tax Provision of 30.8 K, Net Interest Income of 9.9 M or Interest Income of 9.9 M, as well as many indicators such as Price To Sales Ratio of 9.07, Dividend Yield of 0.0 or PTB Ratio of 4.99. Rxsight financial statements analysis is a perfect complement when working with Rxsight Valuation or Volatility modules.
  
Build AI portfolio with Rxsight Stock
Check out the analysis of Rxsight Correlation against competitors.
For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.

Rxsight Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets193.4 M318.6 M140.2 M
Slightly volatile
Short and Long Term Debt Total18.9 M12.3 M13.1 M
Slightly volatile
Other Current Liabilities11 M17.2 M7.4 M
Slightly volatile
Total Current Liabilities17.4 M25.9 M11.8 M
Slightly volatile
Other Liabilities130.6 M123.2 M168.6 M
Slightly volatile
Property Plant And Equipment Net19.1 M23.6 M18.5 M
Pretty Stable
Current Deferred Revenue3.3 M3.1 M912.8 K
Slightly volatile
Accounts Payable2.9 M4.5 M2.4 M
Slightly volatile
Cash15.5 M16.7 M10.7 M
Slightly volatile
Non Current Assets Total20.2 M24.7 M19.5 M
Pretty Stable
Non Currrent Assets Other1.2 M1.1 M282.7 K
Slightly volatile
Other Assets1.1 M1.8 M1.1 M
Slightly volatile
Cash And Short Term Investments142.9 M237.2 M103 M
Slightly volatile
Net Receivables31.6 M30.1 M6.8 M
Slightly volatile
Common Stock Total Equity23.9 K25.2 K40.3 M
Slightly volatile
Common Stock Shares Outstanding33.7 M38.9 M29.1 M
Slightly volatile
Short Term Investments127.4 M220.5 M92.3 M
Slightly volatile
Liabilities And Stockholders Equity193.4 M318.6 M140.2 M
Slightly volatile
Non Current Liabilities Total10.9 M11.4 M285.2 M
Slightly volatile
Capital Lease Obligations6.8 M12.3 M5.9 M
Slightly volatile
Inventory14.3 M22 M9.8 M
Slightly volatile
Other Current AssetsM4.5 M2.5 M
Slightly volatile
Total Liabilities35.5 M37.3 M297.4 M
Slightly volatile
Property Plant And Equipment Gross27.2 M49.1 M21.8 M
Slightly volatile
Total Current Assets173.2 M293.8 M120.6 M
Slightly volatile
Capital Stock38 K40 K40.3 M
Slightly volatile
Net Working Capital155.8 M267.9 M108.8 M
Slightly volatile
Short Term Debt925.3 K974 K1.4 M
Slightly volatile
Common Stock38 K40 K40.3 M
Slightly volatile
Property Plant Equipment11.8 M9.1 M16.5 M
Slightly volatile
Long Term Debt39.6 M46.2 M29.9 M
Slightly volatile
Long Term Debt Total34.7 M39.1 M42.6 M
Slightly volatile
Capital Surpluse689.4 M731.4 M631.4 M
Slightly volatile
Non Current Liabilities Other110.5 K127 K79.6 K
Slightly volatile

Rxsight Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Tax Provision30.8 K50 K25.9 K
Pretty Stable
Interest Income9.9 M9.5 M3.2 M
Slightly volatile
Depreciation And Amortization3.2 M3.6 M3.9 M
Slightly volatile
Interest Expense19.9 K21 K796.7 K
Slightly volatile
Selling General Administrative54.6 M101.4 M30.6 M
Slightly volatile
Total Revenue146.9 M139.9 M30.3 M
Slightly volatile
Other Operating Expenses110.5 M176.8 M72 M
Slightly volatile
Research Development30.3 M34.4 M28.9 M
Very volatile
Cost Of Revenue25.5 M41 M12.6 M
Slightly volatile
Total Operating Expenses85 M135.8 M59.5 M
Slightly volatile
Reconciled Depreciation3.2 M3.6 M3.9 M
Slightly volatile
Income Tax Expense30.8 K50 K25.9 K
Pretty Stable
Non Operating Income Net Other1.7 M1.4 M2.5 M
Slightly volatile

Rxsight Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation12.5 M24.6 M7.6 M
Slightly volatile
Begin Period Cash Flow16.7 M10.4 M39.3 M
Slightly volatile
Depreciation3.2 M3.6 M3.9 M
Slightly volatile
Capital Expenditures3.9 M5.4 M3.9 M
Pretty Stable
Total Cash From Financing Activities65.1 M123.3 M27 M
Slightly volatile
End Period Cash Flow16.3 M17.5 M11.5 M
Slightly volatile
Dividends Paid514.4 K578.7 K630.9 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio9.079.5498129
Slightly volatile
Days Sales Outstanding95.5978.3855111
Slightly volatile
Stock Based Compensation To Revenue0.190.21.3711
Slightly volatile
Capex To Depreciation0.621.020.9304
Slightly volatile
EV To Sales9.049.5183128
Slightly volatile
Inventory Turnover1.351.86211.034
Slightly volatile
Days Of Inventory On Hand296196485
Slightly volatile
Payables Turnover7.049.01944.7794
Slightly volatile
Research And Ddevelopement To Revenue0.230.24568.491
Slightly volatile
Capex To Revenue0.03690.03891.1669
Slightly volatile
Cash Per Share3.316.10333.4032
Slightly volatile
Days Payables Outstanding69.3640.4685139
Slightly volatile
Current Ratio11.1511.35510.4978
Very volatile
Receivables Turnover3.494.65653.449
Slightly volatile
Capex Per Share0.0880.140.131
Slightly volatile
Revenue Per Share3.783.60010.8691
Slightly volatile
Interest Debt Per Share0.30.31690.47
Slightly volatile
Debt To Assets0.03670.03860.0893
Slightly volatile
Operating Cycle392274595
Slightly volatile
Days Of Payables Outstanding69.3640.4685139
Slightly volatile
Quick Ratio10.2610.50459.6597
Very volatile
Net Income Per E B T0.81.00180.9874
Slightly volatile
Cash Ratio1.120.64560.9832
Very volatile
Cash Conversion Cycle323234456
Slightly volatile
Days Of Inventory Outstanding296196485
Slightly volatile
Days Of Sales Outstanding95.5978.3855111
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.91.3211.0937
Very volatile
Fixed Asset Turnover6.225.92161.6086
Slightly volatile
Debt Ratio0.03670.03860.0893
Slightly volatile
Price Sales Ratio9.079.5498129
Slightly volatile
Asset Turnover0.460.43920.1362
Slightly volatile

Rxsight Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap676.8 M1.3 B465.5 M
Slightly volatile
Enterprise Value685.3 M1.3 B482.8 M
Slightly volatile

Rxsight Fundamental Market Drivers

Forward Price Earnings116.2791
Cash And Short Term Investments237.2 M

Rxsight Upcoming Events

4th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Rxsight Financial Statements

Rxsight shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Rxsight investors may analyze each financial statement separately, they are all interrelated. The changes in Rxsight's assets and liabilities, for example, are also reflected in the revenues and expenses on on Rxsight's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue3.1 M3.3 M
Total Revenue139.9 M146.9 M
Cost Of Revenue41 M25.5 M
Stock Based Compensation To Revenue 0.20  0.19 
Research And Ddevelopement To Revenue 0.25  0.23 
Capex To Revenue 0.04  0.04 
Revenue Per Share 3.60  3.78 
Ebit Per Revenue(0.26)(0.28)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Rxsight Stock Analysis

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.